CD274 and cancer: Moreover, based on findings from studies across different cancer types [35,36], its interaction with receptors directly influences immune checkpoint pathways, such as PD-1 and PD-L1, and its potential impact on resistance mechanisms suggest that it is a promising therapeutic target in cancer immunotherapy.